Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Publication Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…Certara2025 年 10 月 31 日
Key lessons & opportunities in applying NCA and PopPK to ADCs Blog Key lessons & opportunities in applying NCA and PopPK to ADCs Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…Certara2025 年 10 月 24 日
AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success On-Demand Webinar AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…Certara2025 年 10 月 21 日
Everything you need to know about SDTM Blog 关于 SDTM 您需要了解的一切 Find out all you need to know about CDISC SDTM, from the SDTM implementation guide…Ed Chappell2025 年 10 月 16 日
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Publication Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…Certara2025 年 10 月 15 日
RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging On-Demand Webinar RAPS 赞助的网络研讨会:Planning and Preparing Regulatory Submissions Using Top-down Messaging Access our on-demand webinar and explore proven strategies to develop consistent, high-impact regulatory submission messages.Certara2025 年 10 月 9 日
Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准 Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…Certara2025 年 10 月 2 日
37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Conference 37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Certara2025 年 9 月 22 日